CMF - Center for Molecular Fingerprinting
Laszlo Vastag MD MBA has extensive experience in clinical operations and management within the pharmaceutical and healthcare sectors. Currently serving as the Managing Director at CMF - Center for Molecular Fingerprinting since April 2020, Laszlo has previously held significant roles at Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézet as Professional Leader and Expert, and at PAREXEL as Senior Manager and Manager of Clinical Operations. Prior experience includes working as Clinical Operations Manager at Amgen and as a Clinical Research Associate and Project and Performance Manager at M. E. Trial Masters Ltd., among other positions. Laszlo holds an Executive MBA from Corvinus University of Budapest, Maastricht School of Management, Maastricht University, and SEED School for Executive Education and Development, and earned a Doctor of Medicine from the University of Pécs.
This person is not in any teams
This person is not in any offices
CMF - Center for Molecular Fingerprinting
Our goal is to develop, validate and establish a simple method for the ‘molecular fingerprinting’ of blood samples, based on the use of an innovative, cutting-edge, ultrafast laser technology. At present, many types of cancer can only be reliably detected by careful examination of multiple tissue samples (biopsies). Our new method dispenses with the need for biopsies, as it is designed to detect the changes in the chemical composition of the blood that reveal the presence of cancer cells in the body, i.e. the cancer’s molecular fingerprint. Our efforts are primarily focused on the development of oncological diagnostics for the most common malignancies: cancers of the breast, lung and prostate gland.